China Ming Yang Wind Power (NYSE: MY) (“Ming Yang” or the “Company”), today announced its subsidiary, Guangdong Mingyang Wind Power Group Limited, (“Guangdong Mingyang”), has signed a framework agreement (the \
Mehta Eye Clinic, a leading Eye care specialty clinic in Ghatkopar, Mumbai, has always been on the forefront of technology. With an aspiration to bring the latest and most advanced Eye Care technology for patients, Mehta Eye Clinic has always believed in investing in the best. The Clinic has recently introduced LenSx® -the first of its kind, completely bladeless Laser Assisted Cataract Surgery in the city of Mumbai.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64151-mehta-eye-clinic-laser-cataract-surgery
Volvo Cars will play a leading role in the world’s first large-scale autonomous driving pilot project in which 100 self-driving Volvo cars will use public roads in everyday driving conditions around the Swedish city of Gothenburg.
The aim is to pinpoint the societal benefits of autonomous driving and position Sweden and Volvo Cars as leaders in the development of future mobility.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64153-volvo-self-driving-cars-unique-swedish-project
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
